Wells Fargo analyst Elyse Greenspan maintains Allstate (NYSE:ALL) with a Underweight and lowers the price target from $116 to $110.
One Analyst Is Bullish On Medtronic, Another Is Not Post Q1 Earnings
Citi says that Medtronic plc (NYSE: MDT) delivered better-than-expected FY1Q23 results, reiterating FY23 guidance despite the ongoing litany of pressures impacting Medtech.